None listed
Conditions
Interventions
Measurement A: Wear Measurement Device under developing for up to 3 hours Measurement B:Wear Measurement Device under developing for up to 2 hours x 3 times x 2 days
Sponsors
APO PLUS STATION CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy Japanese men and women between the ages of 20 and 60 at the time of consent. 2)Participants who have been fully informed of the purpose and content of the study, and submit the written informed consent form. 3)Participants who can report their own urge to urinate. 4)Participants who can comply with the restrictions from the day before the study.
Exclusion criteria
Exclusion criteria: 1)Participants who currently suffer from or have a history of serious heart disease, pulmonary disease, digestive system disease (esophagus, stomach, small intestine, large intestine, liver, pancreas, etc.), high blood pressure, diabetes, malignant tumors, etc. 2)Participants who are currently undergoing treatment for the following chronic diseases: arrhythmia, liver disorder, kidney disorder, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension, and other chronic diseases. 3)Participants with a medical history related to urination who are currently receiving treatment. 4)Participants who are aware of frequent urination. 5)Participants who cannot drink 500 mL of water within 15 minutes. 6)Participants who regularly use medications, quasi-drugs, or health foods (such as foods for specified health uses, foods with nutrient function claims, foods with functional claims, supplements, etc.) that may affect the various tests conducted within this study. 7)Participants who are currently receiving treatment at a medical institution for diseases that may affect the various tests conducted within this study. 8)Participants who have or may have metallic foreign objects in or on the surface of their abdomen. 9)Participants who are participating in a clinical study or have participated in another clinical study within 1 month from the date of obtaining consent. 10)Participants who plan to participate in another clinical study during the study period. 11)Participants who may develop skin irritation from contact with medical tape or similar materials. 12)Participants who judged as unsuitable for this study by the principal investigator for any reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of data obtained from the currently developing Device (study device) and Ultrasound Echo | — |
Countries
Japan
Contacts
Public ContactMasako Mizuuchi
APO PLUS STATION CO., LTD. Clinical Operations Dept., CRO Business div.
Outcome results
None listed